In a catalog with dozens or hundreds of SKUs, underpriced products often hide in plain sight — selling steadily, looking healthy on a revenue report, while quietly returning far less margin than they should. The real cost to your business is substantial: every underpriced unit compounds across your entire sales volume, eroding profitability in ways that don’t always show up clearly in monthly P&L statements.
Where to look first
- Products where cost has crept up since the price was last set — a common and easy-to-miss cause. For example, if a supplier raised costs by 8% but your price stayed flat for 18 months, you’ve slowly destroyed your margin on that SKU.
- High-volume sellers, since a small per-unit underpricing multiplies fast at scale. A product selling 500 units per month with just a $2 margin shortfall is costing you $12,000 annually in lost profit.
- Products priced mainly by matching a competitor, without checking your own cost structure. Your competitor may have different supplier agreements, overhead, or fulfillment costs — their price isn’t your benchmark.
A quick audit method
Sort your catalog by margin percentage (lowest first), then cross-reference against sales volume. Create a simple matrix: plot products on two axes, with margin percentage on one side and monthly unit sales on the other. A low-margin, high-volume product is worth investigating immediately; a low-margin, low-volume product is lower priority.
For example, if Product A has a 12% margin and sells 600 units monthly, versus Product B with an 8% margin selling 80 units monthly, Product A should be your first target — even though both are underperforming.
What to do once you find one
Don’t assume a price increase is the only fix — sometimes the real problem is cost, not price, and negotiating a better input cost solves the margin issue without touching what the customer pays. Before raising prices, audit your supplier agreements, manufacturing processes, and fulfillment methods. A 5% reduction in COGS has the same bottom-line impact as a 5% price increase, with zero customer friction.
The data says underpricing is the default risk, not overpricing
Pricing research consistently points the same direction: analysts at McKinsey have found that 80–90% of mispriced products are priced too low, not too high. One large-scale B2B pricing analysis found that roughly 89% of products were underpriced by at least 3.5%. The bias runs toward leaving money on the table, not scaring customers away.
The leverage is bigger than it looks, too: a 1% price increase, with no drop in volume, translates to roughly an 11.1% increase in operating profit for a typical business, because that extra revenue mostly skips straight past your existing fixed costs. In concrete terms, if you have $500,000 in annual operating profit and raise prices by 1%, you’re looking at roughly $55,500 in additional profit — assuming no volume loss.
Practical signals a product is underpriced
- It sells out immediately at every restock. Consistent, fast sell-through is usually read as a win, but it’s one of the clearest underpricing signals in a catalog — demand is outrunning price. If you’re restocking weekly and still can’t keep inventory, the price is likely 10–15% too low.
- Its margin sits meaningfully below your catalog average with no strategic reason (loss leader, clearance, market entry) for it to be there. If your average margin is 38% but a core product runs at 22%, that’s a red flag.
- It hasn’t had a price review in 12+ months while input costs have moved. Rule of thumb: review pricing quarterly, minimum, for high-volume SKUs.
- Competitors are priced noticeably higher for a comparable product with no clear quality gap explaining the difference. A 15–20% price gap warrants investigation; a 30%+ gap suggests your pricing is significantly out of line.
Common mistake
Treating a fast-selling, low-margin product as a success story rather than a pricing signal. Strong sell-through with weak margin is usually evidence the price should move up, not proof the price is right. The revenue looks healthy, but the profit tells a different story.